IONS Ionis Pharmaceuticals Inc

Price (delayed)

$43.35

Market cap

$6.32B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.56

Enterprise value

$7.36B

Ionis Pharmaceuticals is a biotechnology company based in Carlsbad, California that specializes in discovering and developing RNA-targeted therapeutics. The company has 3 commercially approved medicines: Spinraza , Tegsedi , and ...

Highlights
The gross profit is up by 36% year-on-year and by 29% since the previous quarter
IONS's revenue is up by 34% YoY and by 28% QoQ
The net income has declined by 36% year-on-year but it has increased by 11% since the previous quarter
Ionis Pharmaceuticals's EPS has decreased by 35% YoY but it has increased by 11% QoQ
IONS's quick ratio is down by 16% year-on-year and by 8% since the previous quarter
The company's debt rose by 6% YoY

Key stats

What are the main financial stats of IONS
Market
Shares outstanding
145.75M
Market cap
$6.32B
Enterprise value
$7.36B
Valuations
Price to book (P/B)
16.08
Price to sales (P/S)
7.88
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
9.35
Earnings
Revenue
$787.65M
EBIT
-$252.51M
EBITDA
-$230.01M
Free cash flow
-$331.3M
Per share
EPS
-$2.56
Free cash flow per share
-$2.31
Book value per share
$2.7
Revenue per share
$5.5
TBVPS
$20.88
Balance sheet
Total assets
$2.99B
Total liabilities
$2.6B
Debt
$1.44B
Equity
$386.69M
Working capital
$2.19B
Liquidity
Debt to equity
3.74
Current ratio
5.9
Quick ratio
5.42
Net debt/EBITDA
-4.55
Margins
EBITDA margin
-29.2%
Gross margin
98.8%
Net margin
-46.5%
Operating margin
-44.9%
Efficiency
Return on assets
-12.4%
Return on equity
-90.6%
Return on invested capital
-6.9%
Return on capital employed
-9.9%
Return on sales
-32.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IONS stock price

How has the Ionis Pharmaceuticals stock price performed over time
Intraday
-2.93%
1 week
1.4%
1 month
-6.85%
1 year
26.42%
YTD
-14.31%
QTD
-14.31%

Financial performance

How have Ionis Pharmaceuticals's revenue and profit performed over time
Revenue
$787.65M
Gross profit
$778.51M
Operating income
-$353.73M
Net income
-$366.29M
Gross margin
98.8%
Net margin
-46.5%
The operating margin has surged by 50% since the previous quarter and by 36% year-on-year
The gross profit is up by 36% year-on-year and by 29% since the previous quarter
The net income has declined by 36% year-on-year but it has increased by 11% since the previous quarter
IONS's operating income is up by 36% since the previous quarter and by 14% year-on-year

Growth

What is Ionis Pharmaceuticals's growth rate over time

Valuation

What is Ionis Pharmaceuticals stock price valuation
P/E
N/A
P/B
16.08
P/S
7.88
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
9.35
Ionis Pharmaceuticals's EPS has decreased by 35% YoY but it has increased by 11% QoQ
The stock's price to book (P/B) is 71% more than its 5-year quarterly average of 9.4
The company's equity fell by 33% YoY but it rose by 23% QoQ
IONS's revenue is up by 34% YoY and by 28% QoQ
The P/S is 17% less than the last 4 quarters average of 9.5 and 9% less than the 5-year quarterly average of 8.7

Efficiency

How efficient is Ionis Pharmaceuticals business performance
IONS's return on equity has dropped by 110% year-on-year
Ionis Pharmaceuticals's return on sales has increased by 37% QoQ and by 24% YoY
Ionis Pharmaceuticals's ROIC has increased by 22% from the previous quarter and by 16% YoY
IONS's return on assets is up by 14% since the previous quarter but it is down by 14% year-on-year

Dividends

What is IONS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IONS.

Financial health

How did Ionis Pharmaceuticals financials performed over time
The total assets is 15% greater than the total liabilities
The total liabilities is up by 33% year-on-year
The total assets is up by 18% year-on-year
Ionis Pharmaceuticals's debt to equity has soared by 57% YoY but it has decreased by 19% from the previous quarter
The company's equity fell by 33% YoY but it rose by 23% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.